The Serum Institute of India (SII) will soon seek market authorisation as well as a manufacturing licence from the Drugs Controller General of India (DCGI) for the Quadrivalent Human Papillomavirus (qHPV) vaccine against cervical cancer.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/FvsDg13
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» SII seeks govt's nod to manufacture, stockpile qHPV vaccine against cervical cancer
https://ift.tt/J28n3t4
No comments:
Post a Comment